01/26 StreetInsider.com Pre-Open Movers:

Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) 27% HIGHER; Reports Positive Phase III Results for Eculizumab

This article: 377 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE